Image Credits: Extivita-RTP Article cited by: PRN NEWSBOCA RATON, Fla., Sept. 14, 2022 /PRNewswire/ -- From breakthroughs in the prevention of post-concussion syndrome to unprecedented advances in post-stroke, traumatic brain injury and spinal cell regeneration,...
From Neurology LiveThe director of the Sagol Center for Hyperbaric Medicine and Research at Yitzhak Shamir Medical Center discusses how hyperbaric oxygen therapy is being used to attempt to improve the damage from neurodegeneration. Read the full article...
Dr. Harch joins Sound Health Radio to share what his research has revealed about HBOT and how it can help those suffering from brain injury or diseases such as: stroke, autism, cerebral palsy, Alzheimer's, Parkinson's, and more! Dr. Paul Harch is a...
When artist, Darcy Wilson's right eye suffered from 1/3 vision loss after a stroke, her Ophthalmologist urgently sent her over to the Mercy Medical Center's Wound, Healing and Hyperbaric Center to immediately start hyperbaric oxygen therapy (HBOT). "The reason...
One of the largest hyperbaric chamber centers in the world, The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, announced study results which indicate that HBOT (hyperbaric oxygen therapy) produced significant improvement in most cognitive...
The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.
Through the use of hyperbaric, oxygen-rich chambers, medical researchers have found a way to restore a significant amount of neurological function in brain tissue thought to be chronically damaged by stroke, traumatic injury, and metabolic disorder -- even years after...